Abstract: A system described herein includes a receiver component that receives a first graphical user interface of a first computer-executable application and a second graphical user interface of a second computer-executable application. The system also includes an integration component that automatically causes a portion of the first graphical user interface and a portion of the second graphical user interface to be simultaneously displayed on a display screen in an integrated graphical user interface that appears to an end user as being a single application.

Abstract: A system described herein includes a receiver component that receives a first graphical user interface of a first computer-executable application and a second graphical user interface of a second computer-executable application. The system also includes an integration component that automatically causes a portion of the first graphical user interface and a portion of the second graphical user interface to be simultaneously displayed on a display screen in an integrated graphical user interface that appears to an end user as being a single application.

Abstract: A wear indicator for a friction clutch which is located in the drive train in a housing between an engine and a transmission. The wear indicator includes a marking which is stationary relative to the housing during operation of the friction clutch, and a marking which is movable during the engagement and/or disengagement movement of the clutch during operation. When observed in a pre-determined limit position, in particular when the clutch is engaged or released as far as possible, the two markings move closer to one another as clutch wear increases. A distance between the two markings which has been essentially reduced to zero indicates that the clutch has reached its maximum allowable wear. It thus becomes possible to easily and unambiguously check the wear of the clutch, even in situations were access to the clutch is difficult.

Abstract: Novel cardenolides having desirable cardiac activity and which are readily reabsorbed internally, a process for their preparation and therapeutic compositions containing said cardenolides are disclosed.